Further investigation into the role of CLOCK, BMLA1 and NOTCH genes involved in brain tumor progress, and a better understanding of these genes potential in triggering or modulating brain cancer may prove to be the key to early diagnosis of glioma in patients affected by a modest headache and strengthening the therapeutic role of these genes already known in clinical trials. The gene discussed is CLOCK; the disease is central nervous system cancer.